E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 9/28/2006 in the Prospect News Biotech Daily.

Hologic gets $150 million amended and restated revolver

By Sara Rosenberg

New York, Sept. 28 - Hologic Inc. closed on a $150 million amended and restated revolving credit facility due Sept. 24, 2011, according to an 8-K filed with the Securities and Exchange Commission Thursday.

Bank of America acted as the lead bank on the deal.

Pricing on the revolver can range from Libor plus 62.5 to 100 basis points, depending on the company's consolidated leverage ratio.

There is a $50 million accordion feature.

The new facility, which was completed on Sept. 25, replaces the company's previous $75 million revolver that was set to mature on Jan. 23, 2007.

Borrowings are available for working capital, capital expenditures, general corporate purposes and permitted acquisitions.

Hologic is a Bedford, Mass.-based developer, manufacturer and supplier of diagnostic and medical imaging systems.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.